Nektar Therapeutics is developing a painkiller that may enter the brain too slowly to be abused.
Susan YoungFollow @twitterapi
I’m the biomedicine editor for MIT Technology Review. I look for stories where technology stands to improve human health or advance our understanding of the human condition.
I joined MIT Technology Review in March 2012 after a brief stint in the Washington, D.C., news bureau of the scientific journal Nature. Before I ventured to the East Coast, I spent several years in the San Francisco Bay Area as a doctoral student in molecular biology and one whirlwind year in science-writing boot camp in Santa Cruz.
In California, I wrote for the Stanford University press offices, the Multiple Sclerosis Discovery Forum, and the Salinas Californian newspaper. I grew up in a small town in eastern Texas, surrounded by bird song, rolling cattle fields, and lanky pine trees. When I’m not exploring health tech, you will probably find me cooking or giggling over an exceptional LOLcat.
Susan Young's Stories
Researchers have grown brain tissue with distinct regions that mimic different functional structures of the developing brain.
A real-time MRI system can help surgeons perform faster and safer brain operations.
Researchers show off flashing fish brains and the technology behind them.
A nerve-stimulating electrical implant could give people a drug-free alternative to current treatments.
Glowing bunnies are a successful early step in a project aimed at engineering mammals that produce medicines in their milk.
A startup called Genome Liberty is developing a consumer genetics test to gauge an individual’s ability to metabolize prescription drugs.
Princeton researchers, using a 3-D printer, have built a bionic ear with integrated electronics.
Human tests of an electrode implanted deep into the brain could one day lead to smart, self-regulating implants.
A detailed neuron-wiring diagram of the fruit fly's optic lobe helps explain how neurons work together to compute data.